Horn Howard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-02$22.84/sh−3,150$71,946→ 91,996 total
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.